Terms: = Pancreatic cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG
558 results:
1. Molecular pathway of pancreatic cancer-associated neuropathic pain.
Giri SS; Tripathi AS; Erkekoğlu P; Zaki MEA
J Biochem Mol Toxicol; 2024 Apr; 38(4):e23638. PubMed ID: 38613466
[TBL] [Abstract] [Full Text] [Related]
2. Mucin 1 and venous thrombosis in tumor-bearing mice and patients with cancer.
Kawano T; Englisch C; Hisada Y; Paul D; Archibald S; Grover S; Pabinger I; Ay C; Mackman N
Thromb Res; 2024 May; 237():23-30. PubMed ID: 38547690
[TBL] [Abstract] [Full Text] [Related]
3. The muc1-HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling.
Murthy D; Attri KS; Suresh V; Rajacharya GH; Valenzuela CA; Thakur R; Zhao J; Shukla SK; Chaika NV; LaBreck D; Rao CV; Hollingsworth MA; Mehla K; Singh PK
Proc Natl Acad Sci U S A; 2024 Apr; 121(14):e2315509121. PubMed ID: 38547055
[TBL] [Abstract] [Full Text] [Related]
4. Electrochemiluminescence biosensor for specific detection of pancreatic ductal carcinoma through dual targeting of muc1 and miRNA-196a.
Chen Y; Ye Z; Ma M; Yang J; Liu R; Zhang Y; Ma P; Song D
Biosens Bioelectron; 2024 Jun; 254():116241. PubMed ID: 38527406
[TBL] [Abstract] [Full Text] [Related]
5. Mucin-1-Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host.
Zhou R; Wu ST; Yazdanifar M; Williams C; Sanders A; Brouwer C; Maher J; Mukherjee P
J Immunother; 2024 Apr; 47(3):77-88. PubMed ID: 38270462
[TBL] [Abstract] [Full Text] [Related]
6. Relationship Between Immunophenotypes, Genetic Profiles, and Clinicopathologic Characteristics in Small Bowel Adenocarcinoma.
Hoshimoto A; Tatsuguchi A; Yamada T; Kuriyama S; Hamakubo R; Nishimoto T; Omori J; Akimoto N; Gudis K; Mitsui K; Tanaka S; Fujimori S; Hatori T; Shimizu A; Iwakiri K
Am J Surg Pathol; 2024 Feb; 48(2):127-139. PubMed ID: 38062562
[TBL] [Abstract] [Full Text] [Related]
7. pancreatic ductal adenocarcinoma with acinar-to-ductal metaplasia-like cancer cells shows increased cellular proliferation.
Nishimon R; Yoshida K; Sanuki F; Nakashima Y; Miyake T; Sato T; Tomiyama Y; Nishina S; Moriya T; Shiotani A; Hino K
Pancreatology; 2023 Nov; 23(7):811-817. PubMed ID: 37659916
[TBL] [Abstract] [Full Text] [Related]
8. Epigenetic deregulation of MLF1 drives intrahepatic cholangiocarcinoma progression through EGFR/AKT and Wnt/β-catenin signaling.
Tang Z; Yang Y; Chen W; Liang T
Hepatol Commun; 2023 Aug; 7(8):. PubMed ID: 37486965
[TBL] [Abstract] [Full Text] [Related]
9. A Single-Molecule Bioelectronic Portable Array for Early Diagnosis of pancreatic cancer Precursors.
Genco E; Modena F; Sarcina L; Björkström K; Brunetti C; Caironi M; Caputo M; Demartis VM; Di Franco C; Frusconi G; Haeberle L; Larizza P; Mancini MT; Österbacka R; Reeves W; Scamarcio G; Scandurra C; Wheeler M; Cantatore E; Esposito I; Macchia E; Torricelli F; Viola FA; Torsi L
Adv Mater; 2023 Oct; 35(42):e2304102. PubMed ID: 37452695
[TBL] [Abstract] [Full Text] [Related]
10. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
11. Intraoperative pancreatoscopy can improve the detection of skip lesions during surgery for intraductal papillary mucinous neoplasia: A pilot study.
Arnelo U; Valente R; Scandavini CM; Halimi A; Mucelli RMP; Rangelova E; Svensson J; Schulick RD; Torphy RJ; Fagerström N; Moro CF; Vujasinovic M; Matthias Löhr J; Del Chiaro M
Pancreatology; 2023 Sep; 23(6):704-711. PubMed ID: 37336668
[TBL] [Abstract] [Full Text] [Related]
12. The prognostic role of epidermal growth factor receptor mutation in completely resected ampullary adenocarcinoma.
Varol U; Cakır E; Aktas S; Altun ZS; Dilek FH; Butun O; Salman T; Unlu AGD; Alacacioglu A; Somali I
Pol J Pathol; 2023; 74(1):18-28. PubMed ID: 37306349
[TBL] [Abstract] [Full Text] [Related]
13. Visualization research on ENT1/NIS dual-function gene therapy to reverse drug resistance mediated by muc1 in GEM-resistant pancreatic cancer.
Xi Y; Chen H; Xi Y; Hai W; Qu Q; Zhang M; Li B
Nucl Med Biol; 2023; 120-121():108350. PubMed ID: 37229950
[TBL] [Abstract] [Full Text] [Related]
14. Glucocorticoids promote lung metastasis of pancreatic cancer cells through enhancing cell adhesion, migration and invasion.
Wang Y; Su J; Zhou P; Pan XY; Huang GX; Yin LJ; Lu J
Endocr J; 2023 Jul; 70(7):731-743. PubMed ID: 37164685
[TBL] [Abstract] [Full Text] [Related]
15. The ema Assessment of Asciminib for the Treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With at Least Two Tyrosine Kinase Inhibitors.
Tesileanu CMS; Michaleas S; Gonzalo Ruiz R; Mariz S; Fabriek BO; van Hennik PB; Dedorath J; Dekic B; Unkrig C; Brandt A; Koenig J; Enzmann H; Delgado J; Pignatti F
Oncologist; 2023 Jul; 28(7):628-632. PubMed ID: 37141403
[TBL] [Abstract] [Full Text] [Related]
16. Machine learning versus regression for prediction of sporadic pancreatic cancer.
Chen W; Zhou B; Jeon CY; Xie F; Lin YC; Butler RK; Zhou Y; Luong TQ; Lustigova E; Pisegna JR; Wu BU
Pancreatology; 2023 Jun; 23(4):396-402. PubMed ID: 37130760
[TBL] [Abstract] [Full Text] [Related]
17. Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of pancreatic cancer Cells Through Inhibition of muc1 Expression.
Wei D; Wang L; Liu Y; Hafley MA; Tan L; Lorenzi PL; Yang P; Zuo X; Bresalier RS
Dig Dis Sci; 2023 Jul; 68(7):3043-3058. PubMed ID: 37071246
[TBL] [Abstract] [Full Text] [Related]
18. [Immunotherapy in Hepatogastroenterology - update 2022: efficacy and immune-related adverse events].
Krimmel L; Quante M; Bengsch B
Dtsch Med Wochenschr; 2023 Mar; 148(6):294-300. PubMed ID: 36878227
[TBL] [Abstract] [Full Text] [Related]
19. Molecular imaging Theranostics of Neuroendocrine Tumors.
Fortunati E; Bonazzi N; Zanoni L; Fanti S; Ambrosini V
Semin Nucl Med; 2023 Jul; 53(4):539-554. PubMed ID: 36623974
[TBL] [Abstract] [Full Text] [Related]
20. Preliminary Development and Testing of C595 Radioimmunoconjugates for Targeting muc1 cancer Epitopes in pancreatic Ductal Adenocarcinoma.
Hull A; Li Y; Bartholomeusz D; Hsieh W; Tieu W; Pukala TL; Staudacher AH; Bezak E
Cells; 2022 Sep; 11(19):. PubMed ID: 36230945
[TBL] [Abstract] [Full Text] [Related]
[Next]
